Raising a $27m deep tech growth round in a downturn
AccelerComm has announced a $27m Series B, testament to the resilient nature of deep tech.
YellowDog has been working with OMass Therapeutics to accelerate the drug discovery process from over a year to a matter of hours.
Read about the project here.
AccelerComm has announced a $27m Series B, testament to the resilient nature of deep tech.
Foreword from David Leftley (CTO) Light and its compositions has fascinated scientists for more than […]